PL1868631T3 - Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej - Google Patents

Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej

Info

Publication number
PL1868631T3
PL1868631T3 PL06724130T PL06724130T PL1868631T3 PL 1868631 T3 PL1868631 T3 PL 1868631T3 PL 06724130 T PL06724130 T PL 06724130T PL 06724130 T PL06724130 T PL 06724130T PL 1868631 T3 PL1868631 T3 PL 1868631T3
Authority
PL
Poland
Prior art keywords
cosmetic
synthesis
preparation
pharmaceutical composition
sirt proteins
Prior art date
Application number
PL06724130T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Dextraction Des Principes Actifs Sa Vincience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Dextraction Des Principes Actifs Sa Vincience filed Critical Soc Dextraction Des Principes Actifs Sa Vincience
Publication of PL1868631T3 publication Critical patent/PL1868631T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
PL06724130T 2005-04-01 2006-03-30 Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej PL1868631T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0503202A FR2883752B1 (fr) 2005-04-01 2005-04-01 Utilisation de composes inducteurs de la synthese des proteines sirt dans ou pour la preparation d'une composition cosmetique ou pharmaceutique
EP06724130A EP1868631B1 (en) 2005-04-01 2006-03-30 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
PCT/EP2006/003190 WO2006103110A1 (en) 2005-04-01 2006-03-30 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL1868631T3 true PL1868631T3 (pl) 2010-10-29

Family

ID=35350233

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06724130T PL1868631T3 (pl) 2005-04-01 2006-03-30 Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej

Country Status (8)

Country Link
US (1) US7842670B2 (pl)
EP (1) EP1868631B1 (pl)
AT (1) ATE473752T1 (pl)
DE (1) DE602006015449D1 (pl)
ES (1) ES2347070T3 (pl)
FR (1) FR2883752B1 (pl)
PL (1) PL1868631T3 (pl)
WO (1) WO2006103110A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900826B1 (fr) * 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
NZ597056A (en) 2006-12-15 2012-12-21 Colgate Palmolive Co Liquid hand dish detergent having suspended particulate material
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US8703161B2 (en) * 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
US8193155B2 (en) 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
FR2961814B1 (fr) 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
BR102014014999B1 (pt) * 2014-06-18 2020-12-01 Hypera S.A. combinação para proteção da pele contra danos causados pela radiação infravermelha, composição e uso da combinação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064411A1 (en) * 2000-12-08 2003-04-03 Herath Herath Mudiyanselage Athula Chandrasiri Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
US20060084135A1 (en) * 2003-07-01 2006-04-20 Howitz Konrad T Compositions for manipulating the lifespan and stress response of cells and organisms
US20090012130A1 (en) * 2005-01-25 2009-01-08 The Johns Hopkins University Strategies for Designing Drugs that Target the Sir2 Family of Enzymes

Also Published As

Publication number Publication date
FR2883752B1 (fr) 2008-04-11
ES2347070T3 (es) 2010-10-25
DE602006015449D1 (de) 2010-08-26
US20090082278A1 (en) 2009-03-26
FR2883752A1 (fr) 2006-10-06
US7842670B2 (en) 2010-11-30
WO2006103110A1 (en) 2006-10-05
EP1868631B1 (en) 2010-07-14
ATE473752T1 (de) 2010-07-15
EP1868631A1 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
CL2009000035A1 (es) Compuestos derivados 3-espiro-heterociclo-1il-5h-ciclopentan[d]pirimidin-indol, util para inhibir la actividad de akt quinasa; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de enfermedades tal como cancer, fibrosis quistica, diabetes, enfermedad de alzheimer, entre otras.
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
TW200700357A (en) Benzoic acid ester compounds, compositions, uses and methods related thereto
MX2010005516A (es) Composiciones que comprenden al menos un derivado del acido naftoico, de peroxido de benzoilo y al menos un agente filmogeno.
WO2007005941A3 (en) Liver targeted conjugates
CA2571796A1 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
WO2005123043A3 (en) Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
WO2006042661A3 (en) Oligopeptides and their use in cosmetics
WO2007077318A3 (fr) Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
DE502005009568D1 (de) Pharmazeutische Zubereitungen als Hydrogel, die Diaminooxidase enthalten
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
WO2007003771A3 (fr) Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
WO2006094550A8 (de) Verwendung kosmetischer zubereitungen mit einem gehalt an nicht molekular gebundenem freien sauerstoff
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
SI1771180T2 (sl) Zmes v obliki pršila, ki vsebuje kombinacijo klobetazol propionata in kalcitrola, alkoholna faza in oljna faza
WO2007003773A3 (fr) Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
WO2008050157A3 (en) Ozonated oil formulations
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
WO2006103356A3 (fr) Utilisation de composes inducteurs de la synthese des proteines sirt dans ou pour la preparation d'une composition cosmetique ou pharmaceutique.